ZR2 Bioenergy Limited has announced the successful allotment of 1,23,50,000 additional equity shares following the conversion of Compulsorily Convertible Debentures (CCDs). The company, formerly known as Gujchem Distillers India Limited, completed this significant corporate action on February 14, 2026, as communicated to BSE Limited under Regulation 30 of SEBI listing requirements.

CCD Conversion Details

The conversion involved 1,23,50,000 CCDs being converted into an equal number of equity shares with a face value of Re. 1 each. The conversion was executed at a price of Rs. 65 per share, which includes a premium of Rs. 64 per share over the face value.

Shareholding Impact

The allotment has substantially altered the shareholding pattern of ZR2 Bioenergy Limited. ZR2 Group Holdings Limited, which was the sole investor in this conversion, has seen its stake increase significantly following the transaction.

Share Rights and Listing Process

The newly allotted equity shares will rank pari passu with existing fully paid-up equity shares of the company. This means the new shares carry equal rights in all respects, including:

• Entitlement to dividend distributions
• Voting powers in shareholder meetings
• Rights to asset distribution in case of liquidation, dissolution, or winding up

ZR2 Bioenergy Limited has confirmed that it will make necessary applications to BSE Limited for seeking listing and trading approval for the 1,23,50,000 additional equity shares in due course.

Regulatory Compliance

The company has fulfilled all disclosure requirements under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. The announcement was made in accordance with the circular dated September 09, 2015, bearing reference number CIR/CFD/CMD/4/2015 issued by the Securities and Exchange Board of India. The board meeting to approve this allotment commenced at 10:00 a.m. and concluded at 6:00 p.m. on the same day, with Managing Director Jimmy Olsson (DIN: 06891122) signing the regulatory filing.

ZR2 Bioenergy Limited (formerly Gujchem Distillers India Limited) has announced its unaudited financial results for the quarter ended December 31, 2025, demonstrating a remarkable turnaround in financial performance. The Board of Directors approved these results on February 14, 2026, following comprehensive review by the Audit Committee and statutory auditors.

Quarterly Financial Performance

The company's standalone financial results for Q3FY26 show significant improvement across key metrics. Total income for the quarter reached ₹41.63 lakhs, comprising entirely of other income, as the company reported no revenue from operations during this period.

Nine-Month Performance Analysis

For the nine-month period ended December 31, 2025, ZR2 Bioenergy demonstrated sustained profitability with total income of ₹140.01 lakhs and a net profit of ₹80.96 lakhs, compared to a loss of ₹2.30 lakhs in the corresponding period of the previous year.

Consolidated Results

The consolidated financial results, which include the wholly-owned subsidiary ZR2 Solar Private Limited, show similar positive trends. Consolidated profit for Q3FY26 stood at ₹22.88 lakhs compared to a loss of ₹26.35 lakhs in Q3FY25. The nine-month consolidated profit reached ₹80.54 lakhs.

Corporate Developments

Several significant corporate developments have shaped the company's transformation:

• Change of Control: ZR2 Group Holdings Limited acquired 21,77,110 equity shares (61% stake) from previous management on December 31, 2024, becoming the new promoter
• Subsidiary Formation: ZR2 Solar Private Limited was incorporated on October 4, 2024, to operate renewable energy business including solar, wind, and hydropower
• Capital Raising: The company issued 2,59,22,000 convertible warrants and 1,23,50,000 compulsory convertible debentures at ₹65 per unit during Q2FY25

Financial Structure

The company maintains a paid-up equity share capital of ₹35.69 lakhs with face value of ₹1 each. Other equity stands at ₹13,897.76 lakhs as of March 31, 2025. The financial results have been prepared in accordance with Indian Accounting Standards and subjected to limited review by statutory auditors Bagaria & Co., LLP.

Outlook

With the strategic shift towards renewable energy through its subsidiary and improved operational efficiency reflected in reduced expenses, ZR2 Bioenergy appears positioned for continued growth. The company's transformation from traditional distillery operations to bioenergy and renewable energy sectors marks a significant strategic pivot in its business model.